About
D&D Pharmatech develops peptide-based therapeutics targeting metabolic diseases, including GLP-1 drugs for obesity and MASH, and conducts global clinical trials to advance its pipeline.
Explore D&D Pharmatech's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.